LNAI Stock: Lunai Bioworks Inc. Stock Price, Analysis & Insights
Get live lnai stock price $1.50, comprehensive Lunai Bioworks Inc. stock analysis, charts, news, and expert forecast. Real-time lnai stock data and investment insights.
Loading chart...
Company Overview
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Company Information
- CEO
- David H. Weinstein
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 29
Contact Information
- Website
- http://www.renovarogroup.com
- Address
- 2080 Century Park East
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.39) may provide portfolio stability
Business Model & Strategy
Lunai Bioworks Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO David H. Weinstein, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Lunai Bioworks Inc. competes in the Biotechnology within the broader Healthcare. With 26.7 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Lunai Bioworks Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Lunai Bioworks Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Lunai Bioworks Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Lunai Bioworks Inc.
- ⚠Investors should consider how Lunai Bioworks Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
26.70M
P/E Ratio
-0.19
Beta
0.39
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 26.70M market capitalization
- Trading Volume: 1.40M shares traded today
- Price Range: 52-week range of $0.81 - $21.00
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Lunai Bioworks Inc.
Lunai Bioworks Inc. (LNAI) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 26.70M, the company represents a significant player in its market. The stock is currently trading at $1.50 with a positivedaily change of 29.31%.
The company's 29 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.19, beta of 0.39, and 52-week price range from $0.81 to $21.00when evaluating investment opportunities.
Why Invest in Lunai Bioworks Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under David H. Weinstein
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.